XORTX Joins the Kidney Foundation and Kidney March
● In Support of Research for Treating the 4 Million Canadians
Who Have Chronic Kidney Disease Today ●
CALGARY, Alberta, Sept. 07, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce its participation September 8th through 10th, in the Kidney Foundation’s “Kidney March”, in support of the almost 4 million Canadians who have chronic kidney disease today.
The Company is pleased to participate in this important annual event which supports fund raising to further basic kidney research, and to join the kidney disease support community. This year XORTX has committed to support the Kidney March through sponsorship of Sunday “Kidney March” events and closing ceremonies of the “Kidney March”. Details on the Kidney Foundation and the Kidney March are included in the following links - https://kidney.ca/ and https://kidneymarch.ca/basics/
Dr. Allen Davidoff, XORTX’s CEO stated, “Our efforts this week in support of the Kidney Foundation of Canada is a small contribution, to address a much larger, growing, global problem. It is notable that kidney disease is estimated to affect almost 1 in 7 individuals and because symptoms are few, diagnosis often occurs in mid to late stage of disease. More concerning is an estimated rate of new chronic kidney disease that exceeds 10% per year and doubling the number of cases each decade. Because few therapeutic options exist for individuals with progressing kidney disease, we believe that XORTX’ focus on the development of therapies to slow progression of kidney disease has the potential to improve patient outcomes and quality of life. We encourage everyone to visit the Kidney Foundation of Canada to understand how you can be a part of the solution.”
About the Kidney Foundation of Canada
Since 1964, the Kidney Foundation of Canada has been guided by three fundamental principles: innovation, leadership, and collaboration toward the promotion of excellent kidney health, optimal quality of life for those affected by kidney disease, and a cure. The Kidney Foundation of Canada is the leading charity committed to eliminating the burden of kidney disease through: Funding and stimulating innovative research for better prevention, treatments and a cure; Providing education and support to prevent kidney disease in those at risk and empower those with kidney disease to optimize their health status; Advocating for improved access to high quality health care; Increasing public awareness and commitment to advancing kidney health and organ donation. https://kidney.ca/About-Us/Overview/Our-Mission
